Company Snapshot: ELN  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Elan Announces Webcast of First Quarter 2002 Financial Results

    DUBLIN, Ireland, April 22 /PRNewswire-FirstCall/ -- Elan Corporation, plc
(NYSE: ELN) ("Elan") announced today that it will report first quarter 2002
financial results on May 2, 2002, before the financial markets open.  The
announcement will be followed by a conference call at 8:30 a.m. Eastern Time
with the investment community, and feature members of Elan's Senior Management
Team.
    Live audio of the conference call will be simultaneously broadcast over
the Internet and will be available to members of the news media, investors and
the general public.  The conference call is expected to last approximately one
hour.
    This event can be accessed by to Elan's website, http://www.elan.com, and
clicking on the Investor Relations section, then on the event icon.  The event
will be archived and available for replay for 48 hours after the event.

    Elan Corporation, plc. is a leading worldwide, fully integrated
biopharmaceutical company headquartered in Ireland, with its principal
research, development, manufacturing and marketing facilities located in
Ireland and  the United States.  Elan is focused on the marketing of
therapeutic products and services in neurology, pain management, oncology,
infectious disease and dermatology and on the development and
commercialization of products using its extensive range of proprietary drug
delivery technologies.  Elan shares trade on the New York, London and Dublin
Stock Exchanges.



SOURCE Elan Corporation, plc




Back to Topback to top

Related links:
  • http://www.elan.ie
    Company News On-Call:
  • http://www.prnewswire.com/comp/231593.html
    CONTACT:
    Investors (U.S.), Jack Howarth,
    +1-212-407-5740, 800-252-3526, or Investors (Europe), Emer
    Reynolds, +353-1-709-4000, 00800-28352600, both of Elan
    Corporation, plc